Established · publishing since 1982Rising activity
Pancreatic and Hepatic Oncology ResearchImmune cells in cancerEpigenetics and DNA MethylationCancer Immunotherapy and BiomarkersPhagocytosis and Immune Regulation
Publications
726
Citations
15,891
Est. group size
~113
Recurring co-author estimate
Active years
45
Publishing since 1982
In context
Among 4,953 established Medicine PIs within our index
Citations: 15,891p25 789 · p75 7,423 · cohort median 2,544
Publications / year (recent): 110.4p25 2 · p75 10.6 · cohort median 4.8
Typically publishes in teams of ~33 · 4% small-team papers (≤3 authors) · across 24 venues
Publication cadence
Publications per year over the last 10 years — averaging 110.4/year recently
Collaborators per year
Distinct co-authors at University of Michigan each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
Recent publications
- Supplementary Figure 8 from KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis
2025
- Supplementary Figure 1 from KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis
2025
- Supplementary Figure 2 from KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis
2025
- Supplementary Figure 3 from KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis
2025
- Supplementary Table 2 from KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis
2025
- Supplementary Table 1 from KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis
2025
- Supplementary Table 3 from KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis
2025
- Supplementary Figure 6 from KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis
2025
- Supplementary Figure 7 from KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis
2025
- Supplementary Figure 9 from KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis
2025
- Supplementary Figure 5 from KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis
2025
- Supplementary Figure 10 from KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis
2025
- Supplementary Figure 4 from KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis
2025
- Co-treatment of ticagrelor and anti-PD-1 immunotherapy in tumor-associated macrophages reduces pancreatic cancer cell growth and migration through the TGF-β1/Smad2 pathway
Biomedicine & Pharmacotherapy · 2025
- Tumor-Derived Polyamines Initiate Fat Wasting in Cancer Cachexia
bioRxiv (Cold Spring Harbor Laboratory) · 2025
Publishes in
- Cancer Research×78
- bioRxiv (Cold Spring Harbor Laboratory)×26
- Cellular and Molecular Gastroenterology and Hepatology×11
- Cancer Discovery×9
- Gastroenterology×8
Similar researchers
By research-topic overlap
- Eileen S. Carpenter
Medicine · University of Michigan
- Yaqing Zhang
Medicine · University of Michigan
- Filip Bednar
Medicine · University of Michigan
- Yaqing Zhang
Medicine · University of Michigan
- Zeribe C. Nwosu
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile